Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Source filing unavailable
| Metric | Q2 2014 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Net Income | -$427.57K | -$2.15K | -$1.20K |
| EPS Diluted | -$0.04 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
